Showing results (11-20 of 40) with videos related to
Sort By:
Pageof 4
Journal of Clinical Gastroenterology|February 19, 2003
Nuclear localization of hepatitis B core antigen and its relations to liver injury, hepatocyte proliferation, and viral loadEbru Serinoz, Murat Varli, Esra Erden, et al.Respirology (Carlton, Vic.)|September 2, 2005
Sarcoidosis caused by interferon therapyGöhkan Celik, Elif Sen, A Fusun Ulger, et al.Journal of Gastroenterology and Hepatology|May 19, 2006
Long-term prognosis of nonalcoholic fatty liver disease: is pharmacological therapy actually necessary?Kubilay Cinar, Sahin Coban, Ramazan Idilman, et al.The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|July 21, 2004
The mutations in ISDR of NS5A gene are not associated with response to interferon treatment in Turkish patients with chronic hepatitis C virus genotype 1b infectionNuray Aslan, A Mithat Bozdayi, Hülya Cetinkaya, et al.Digestive Diseases and Sciences|August 20, 2002
Remission of severe aplastic anemia associated with hepatitis B virus infection after viral clearance: potential role of lamivudineHakan Bozkaya, Cihan Yurdaydin, Murat Törüner, et al.Digestive Diseases and Sciences|June 26, 2003
Interferon-alpha2b induction treatment with or without ribavirin in chronic hepatitis C: a multicenter, randomized, controlled trialHakan Senturk, Galip Ersoz, Resat Ozaras, et al.Journal of Clinical Gastroenterology|March 18, 2008
Adjuvant therapeutic plasma exchange in liver failure: assessments of clinical and laboratory parametersMehmet Bektas, Ramazan Idilman, Irfan Soykan, et al.Antiviral Therapy|May 4, 2005
Lamivudine treatment in HBeAg-negative chronic hepatitis B patients with low level viraemiaHakan Bozkaya, Cihan Yurdaydin, Ramazan Idilman, et al.European Journal of Gastroenterology & Hepatology|February 18, 2005
Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosisOzlem Erkan, Abdurrahman M Bozdayi, Selcuk Disibeyaz, et al.Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 22, 2005
Peroxisome proliferator-activated receptor alpha L162V polymorphism in nonalcoholic steatohepatitis and genotype 1 hepatitis C virus-related liver steatosisHasibe Verdi, Elif Sare Koytak, Oğuz Onder, et al.Pageof 4